Related Experiment Video

Updated: May 23, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Inotropic and vasoactive drugs in pediatric ICU

Marco Piastra1, Ersilia Luca, Sonia Mensi

  • 1Pediatric ICU, Catholic University Medical School, Rome, Italy. marco.piastra@rm.unicatt.it

Current Drug Targets
|April 20, 2012
PubMed

Insights

Recognizing and treating circulatory failure in critically ill children is vital. Advanced hemodynamic monitoring offers a reliable method for diagnosing and managing cardiocirculatory instability in pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric cardiology
  • Intensive care medicine

Background:

  • Circulatory failure is a critical concern in critically ill infants and children.
  • Baseline vital signs and lab tests inadequately reflect hemodynamic status in pediatric patients.
  • Effective diagnosis and treatment are essential for survival in pediatric intensive care.

Purpose of the Study:

  • To highlight the need for advanced hemodynamic monitoring in pediatric critical care.
  • To discuss the role of advanced monitoring in diagnosing and managing circulatory failure.
  • To emphasize the importance of monitoring heart performance and vascular status.

Main Methods:

  • Advanced hemodynamic monitoring techniques such as cardiac output measurement.
  • Assessment of fluid responsiveness and systemic oxygen delivery.
  • Utilizing monitoring devices and treatment strategies for vasoactive drugs.

Main Results:

  • Advanced hemodynamic monitoring provides a reliable tool for diagnosis and evolution monitoring.
  • Identification and quantification of pulmonary edema are increasingly recognized.
  • Increased understanding of clinical applications for monitoring devices and treatment strategies.

Conclusions:

  • Early recognition and prompt treatment of circulatory failure are life-saving.
  • Advanced hemodynamic monitoring is crucial for managing cardiocirculatory instability in pediatric intensive care.
  • Continuous advancements in monitoring and treatment strategies improve outcomes for critically ill children.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...